The Impact Of Years Since Transplant On The Clinical Course After SARS-CoV-2 Infection In Heart Transplant Recipients

por Pérez-García, Carlos Nicolás, Aslam, Safia, Cooper, Victoria, Parlon, Barbara, Baby, Tomcy, Dempsey, Eimear, Murphy, Katie, Joyce, Emer
Publicado 2023

Humoral response to heterologous prime‐booster vaccination in heart transplant recipients aged 18–70 years primed with a viral vector SARS‐CoV‐2 vaccine

por Tanner, Richard, Starr, Neasa, Perez‐Garcia, Carlos Nicolas, Chan, Grace, Dempsey, Eimear, Heffernan, Emma, Lynch, Breda, Hannan, Margaret M, Joyce, Emer
Publicado 2022

Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age

por Tanner, Richard, Starr, Neasa, Chan, Grace, Dempsey, Eimear, Heffernan, Emma, Newman, Ellen, O'Neill, James, Hannan, Margaret M., Lynch, Breda, Joyce, Emer
Publicado 2022